Smart Immune et CELLforCURE by SEQENS s'associent pour industrialiser la production des lots cliniques de SMART101
03. Dezember 2024 00:00 ET
|
Smart Immune
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
03. Dezember 2024 00:00 ET
|
Smart Immune
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
Cyber A.I. Group Featured in The Silicon Review Highlighting CyberAI’s Strategic Global Expansion
31. Oktober 2024 07:30 ET
|
Cyber A.I. Group, Inc.
The Silicon Review Features CyberAI as a Top Cybersecurity to watch in 2024 Highlighting Strategic Global Expansion
Smart Immune détermine la dose recommandée de SMART101 pour ses essais cliniques en oncologie
23. Oktober 2024 01:01 ET
|
Smart Immune
La phase I d'escalade de dose de ReSET-02 chez des adultes souffrant de cancers hématologiques est terminée.Le segment randomisé de la phase II de cet essai est en cours.Aucune toxicité limitant la...
Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
23. Oktober 2024 01:01 ET
|
Smart Immune
ReSET-02 dose escalation Phase I is completedPhase II PoC randomized segment is starting No dose-limiting toxicities, no safety or tolerability issuesThe highest dose is to be used in both...
ThinkLabs AI, Inc. Launches and Secures $5M Seed Investment to Develop Technology to Transform Critical Grid Operations
23. Mai 2024 06:00 ET
|
ThinkLabs AI
New York, May 23, 2024 (GLOBE NEWSWIRE) -- ThinkLabs AI, Inc. (ThinkLabs), a new startup focused on developing technology to help enhance grid planning through a combination of intelligent...
YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency
30. Januar 2024 08:00 ET
|
Y-Prime, LLC
YPrime eCOA research reveals stakeholders' concerns about timelines and data quality.
Alabama Futures Fund Invests in Sequence Corporation
29. August 2023 07:00 ET
|
Alabama Futures Fund
BIRMINGHAM, Ala., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Alabama Futures Fund (“AFF” or the “Fund”) recently placed an investment in Sequense Corporation (“Sequense” or “Company”). Based in Austin,...
CHW Launches New Social Impact Investment Fund
04. April 2023 17:04 ET
|
Canadian Hadassah-WIZO (CHW)
TORONTO, April 04, 2023 (GLOBE NEWSWIRE) -- Canadian Hadassah-WIZO (CHW) completed its first round of social impact investing in Israel, as part of the inaugural CHW Journey 4 Impact trip of a...
Maribel Health Raises $25M Series A to Create the Future of Advanced Care at Home
15. März 2023 06:01 ET
|
Maribel Health, Inc
HANOVER, N.H., March 15, 2023 (GLOBE NEWSWIRE) -- Maribel Health, a turnkey partner for health systems looking to design, build, and operate a full continuum of advanced home and community services,...